Skip to main content
. 2015 Sep 1;37(2):189–197. doi: 10.1093/eurheartj/ehv381

Figure 3.

Figure 3

Incidence of BARC-CABG major bleeding stratified by time from discontinuation of clopidogrel/ticagrelor to surgery (P-values denoting difference between the platelet inhibitors, and within clopidogrel/ticagrelor between discontinuation strata as indicated). BARC, Bleeding Academic Research Consortium; CABG, coronary artery bypass grafting.